Results 261 to 270 of about 75,890 (310)

Assessment of Outcomes by Intention-to-Treat Comparison for Locally Advanced Pancreatic Cancer: A Population-Derived Cohort Study. [PDF]

Ann Surg Oncol
Larsson P, Swartling O, Cheraghi D, Khawaja A, Soreide K, Sparrelid E, Ghorbani P.   +6 more
europepmc   +1 more source

Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2. [PDF]

BMC Cancer
Kocher HM, BCI-STARPAC2 team, BPTB team, Precision-Panc team, Sasieni P, Corrie P, McNamara MG, Sarker D, Sarker D, Froeling FEM, Christie A, Gillmore R, Khan K, Propper D.   +13 more
europepmc   +1 more source

The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies. [PDF]

Int J Surg
Fiore M, Petrianni GM, Trecca P, D'Ercole G, Coppola A, La Vaccara V, Taralli S, Cimini P, Greco C, Ippolito E, Calcagni ML, Beomonte Zobel B, Caputo D, Coppola R, Ramella S, D'Angelillo RM.   +15 more
europepmc   +1 more source

Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy: A Single-Center Experience. [PDF]

Ann Surg Oncol
Theijse RT, Stoop TF, Leenart PD, Lutchman KRD, Erdmann JI, Daams F, Zonderhuis BM, Festen S, Swijnenburg RJ, van Gulik TM, Schoorlemmer A, Sterk ALA, van Dieren S, Fariña A, Voermans RP, Wilmink JW, Kazemier G, Busch OR, Besselink MG, For HPB-Amsterdam.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Locally Advanced Pancreatic Cancer

Journal of Clinical Oncology, 2005
Of the 32,180 patients diagnosed with pancreatic carcinoma in the United States this year, approximately 40% will present with locally advanced disease. Radiotherapeutic approaches are often employed because these patients have unresectable tumors by virtue of local invasion into the retroperitoneal vessels in the absence of clinically detectable ...
Christopher G, Willett, Brian G, Czito, Johanna C, Bendell, David P, Ryan   +3 more
openaire   +2 more sources

Irreversible electroporation in locally advanced pancreatic cancer

Pirogov Russian Journal of Surgery, 2023
Objective. To determine the feasibility of irreversible electroporation (IRE) for locally advanced pancreatic adenocarcinoma. Material and methods. Twenty-three patients underwent IRE after chemotherapy for locally advanced pancreatic cancer between 2015 and 2022. IRE was performed during laparotomy as a rule (n=22).
A.N. Polyakov, Yu.I. Patyutko, N.E. Kudashkin, D.M. Kantieva, K.A. Romanova, E.A. Nasonova, A.V. Korshak, O.A. Egenov, D.V. Podluzhnyi   +8 more
openaire   +2 more sources

Therapeutic Advances in Localized Pancreatic Cancer

JAMA Surgery, 2016
It is estimated that pancreatic cancer (PC) will become the second leading cause of cancer-related death in the United States by 2030.Clinical and preclinical data support the understanding that PC metastases occur early in the pathogenesis of this disease, even before the primary tumor can be detected.
Susan, Tsai, Douglas B, Evans
openaire   +2 more sources

Locally Advanced Pancreatic Cancer: A Review

Seminars in Oncology, 2007
It is anticipated that there will be 37,170 new cases of pancreatic cancer diagnosed in the United States this year, resulting in approximately 33,370 deaths from the disease. Approximately 40% of these patients will present with locally advanced, non-metastatic disease. Treatment regimens that incorporate conventional radiation therapy for local tumor
Suzanne, Russo, Jerome, Butler, Roger, Ove, A William, Blackstock   +3 more
openaire   +2 more sources

Management Options in Locally Advanced Pancreatic Cancer

Current Oncology Reports, 2014
Pancreatic ductal adenocarcinoma is a highly lethal cancer that is rarely curable at the time of presentation. Unfortunately, most patients are diagnosed with either metastatic or locally advanced disease, which is not amenable to surgery owing to the high likelihood of incomplete resection.
Omar Y, Mian, Ashwin N, Ram, Richard, Tuli, Joseph M, Herman   +3 more
openaire   +2 more sources

Current management of locally advanced pancreatic cancer

Nature Clinical Practice Gastroenterology & Hepatology, 2005
Almost 30% of patients with pancreatic cancer present with large, locally advanced tumors in the absence of distant metastases. Because surgical resection is frequently contraindicated by vascular invasion, locally advanced pancreatic cancer has a dismal prognosis with a 6-10-month median survival.
Vivek, Maheshwari, A James, Moser
openaire   +2 more sources